{"entity":{"type":"insider","cik":"0001437435","url":"/insider/0001437435","json_url":"/insider/0001437435.json","name":"Tessier-Lavigne Marc","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":102,"n_filings":27,"first":"2008-07-18","last":"2022-11-28","span_basis":"filed_date"},"name_variants":[{"name":"Tessier-Lavigne Marc","source":"filing","n_filings":27,"first_seen":"2008-07-18","last_seen":"2022-11-28"}],"transactions":[{"id":6136217,"accession":"0001714899-22-000148","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001714899-22-000148","line_url":"/filing/0001714899-22-000148#line-1","is_derivative":false,"issuer_cik":"0001437435","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001437435","owner_cik":"0001437435","owner_name":"Tessier-Lavigne Marc","owner_display_name":"Tessier-Lavigne Marc","owner_url":"/insider/0001437435","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":30.48,"price_display":"30.48","price_state":"stated","total_value":609600.0,"total_display":"609,600.00","total_whole":"609,600","shares_owned_after":1870356.0,"shares_owned_after_display":"1,870,356","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-23","filed_date":"2022-11-28","scope":"insider"},{"id":6941040,"accession":"0001714899-22-000146","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001714899-22-000146","line_url":"/filing/0001714899-22-000146#line-2","is_derivative":false,"issuer_cik":"0001437435","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001437435","owner_cik":"0001437435","owner_name":"Tessier-Lavigne Marc","owner_display_name":"Tessier-Lavigne Marc","owner_url":"/insider/0001437435","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11252.0,"shares_display":"11,252","price_per_share":30.33,"price_display":"30.33","price_state":"stated","total_value":341273.16,"total_display":"341,273.16","total_whole":"341,273","shares_owned_after":1890356.0,"shares_owned_after_display":"1,890,356","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-02","filed_date":"2022-11-03","scope":"insider"},{"id":6941037,"accession":"0001714899-22-000146","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001714899-22-000146","line_url":"/filing/0001714899-22-000146#line-1","is_derivative":false,"issuer_cik":"0001437435","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001437435","owner_cik":"0001437435","owner_name":"Tessier-Lavigne Marc","owner_display_name":"Tessier-Lavigne Marc","owner_url":"/insider/0001437435","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8748.0,"shares_display":"8,748","price_per_share":30.2,"price_display":"30.20","price_state":"stated","total_value":264189.6,"total_display":"264,189.60","total_whole":"264,190","shares_owned_after":1901608.0,"shares_owned_after_display":"1,901,608","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-01","filed_date":"2022-11-03","scope":"insider"},{"id":6363856,"accession":"0001883850-22-000072","txn_seq":17,"anchor":"line-17","filing_url":"/filing/0001883850-22-000072","line_url":"/filing/0001883850-22-000072#line-17","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS, INC.","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001437435","owner_name":"Tessier-Lavigne Marc","owner_display_name":"Tessier-Lavigne Marc","owner_url":"/insider/0001437435","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3612.0,"shares_display":"3,612","price_per_share":718.0,"price_display":"718.00","price_state":"stated","total_value":2593416.0,"total_display":"2,593,416.00","total_whole":"2,593,416","shares_owned_after":2269.0,"shares_owned_after_display":"2,269","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-03","filed_date":"2022-10-03","scope":"insider"},{"id":6363854,"accession":"0001883850-22-000072","txn_seq":15,"anchor":"line-15","filing_url":"/filing/0001883850-22-000072","line_url":"/filing/0001883850-22-000072#line-15","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS, INC.","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001437435","owner_name":"Tessier-Lavigne Marc","owner_display_name":"Tessier-Lavigne Marc","owner_url":"/insider/0001437435","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3428.0,"shares_display":"3,428","price_per_share":698.0,"price_display":"698.00","price_state":"stated","total_value":2392744.0,"total_display":"2,392,744.00","total_whole":"2,392,744","shares_owned_after":2269.0,"shares_owned_after_display":"2,269","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-30","filed_date":"2022-10-03","scope":"insider"},{"id":6363852,"accession":"0001883850-22-000072","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0001883850-22-000072","line_url":"/filing/0001883850-22-000072","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS, INC.","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001437435","owner_name":"Tessier-Lavigne Marc","owner_display_name":"Tessier-Lavigne Marc","owner_url":"/insider/0001437435","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3798.0,"shares_display":"3,798","price_per_share":691.0700473933649,"price_display":"691.07","price_state":"stated","total_value":2624684.04,"total_display":"2,624,684.04","total_whole":"2,624,684","shares_owned_after":4084.0,"shares_owned_after_display":"4,084","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-29","filed_date":"2022-10-03","scope":"insider","n_lines":12},{"id":6688858,"accession":"0001714899-22-000133","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001714899-22-000133","line_url":"/filing/0001714899-22-000133","is_derivative":false,"issuer_cik":"0001437435","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001437435","owner_cik":"0001437435","owner_name":"Tessier-Lavigne Marc","owner_display_name":"Tessier-Lavigne Marc","owner_url":"/insider/0001437435","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":30.815191,"price_display":"30.82","price_state":"stated","total_value":616303.82,"total_display":"616,303.82","total_whole":"616,304","shares_owned_after":1914779.0,"shares_owned_after_display":"1,914,779","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-28","filed_date":"2022-09-30","scope":"insider","n_lines":2},{"id":6764392,"accession":"0001714899-22-000131","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001714899-22-000131","line_url":"/filing/0001714899-22-000131","is_derivative":false,"issuer_cik":"0001437435","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001437435","owner_cik":"0001437435","owner_name":"Tessier-Lavigne Marc","owner_display_name":"Tessier-Lavigne Marc","owner_url":"/insider/0001437435","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":31.6141,"price_display":"31.61","price_state":"stated","total_value":632282.0,"total_display":"632,282.00","total_whole":"632,282","shares_owned_after":1930456.0,"shares_owned_after_display":"1,930,456","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-23","filed_date":"2022-08-25","scope":"insider","n_lines":2},{"id":6707228,"accession":"0001714899-22-000109","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001714899-22-000109","line_url":"/filing/0001714899-22-000109","is_derivative":false,"issuer_cik":"0001437435","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001437435","owner_cik":"0001437435","owner_name":"Tessier-Lavigne Marc","owner_display_name":"Tessier-Lavigne Marc","owner_url":"/insider/0001437435","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":35.6055,"price_display":"35.61","price_state":"stated","total_value":712110.0,"total_display":"712,110.00","total_whole":"712,110","shares_owned_after":1950556.0,"shares_owned_after_display":"1,950,556","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-25","filed_date":"2022-07-27","scope":"insider","n_lines":2},{"id":9295204,"accession":"0001714899-22-000101","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001714899-22-000101","line_url":"/filing/0001714899-22-000101","is_derivative":false,"issuer_cik":"0001437435","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001437435","owner_cik":"0001437435","owner_name":"Tessier-Lavigne Marc","owner_display_name":"Tessier-Lavigne Marc","owner_url":"/insider/0001437435","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":33.829126,"price_display":"33.83","price_state":"stated","total_value":676582.52,"total_display":"676,582.52","total_whole":"676,583","shares_owned_after":2024370.0,"shares_owned_after_display":"2,024,370","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-23","filed_date":"2022-06-28","scope":"insider","n_lines":2},{"id":6941032,"accession":"0001714899-22-000061","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001714899-22-000061","line_url":"/filing/0001714899-22-000061","is_derivative":false,"issuer_cik":"0001437435","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001437435","owner_cik":"0001437435","owner_name":"Tessier-Lavigne Marc","owner_display_name":"Tessier-Lavigne Marc","owner_url":"/insider/0001437435","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":33.829126,"price_display":"33.83","price_state":"stated","total_value":676582.52,"total_display":"676,582.52","total_whole":"676,583","shares_owned_after":2024370.0,"shares_owned_after_display":"2,024,370","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-23","filed_date":"2022-03-25","scope":"insider","n_lines":2},{"id":6525638,"accession":"0001708138-22-000027","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001708138-22-000027","line_url":"/filing/0001708138-22-000027#line-2","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS, INC.","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001437435","owner_name":"Tessier-Lavigne Marc","owner_display_name":"Tessier-Lavigne Marc","owner_url":"/insider/0001437435","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7439.0,"shares_display":"7,439","price_per_share":690.0,"price_display":"690.00","price_state":"stated","total_value":5132910.0,"total_display":"5,132,910.00","total_whole":"5,132,910","shares_owned_after":2269.0,"shares_owned_after_display":"2,269","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-21","filed_date":"2022-03-23","scope":"insider"},{"id":6500216,"accession":"0001708138-22-000020","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001708138-22-000020","line_url":"/filing/0001708138-22-000020#line-4","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS, INC.","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001437435","owner_name":"Tessier-Lavigne Marc","owner_display_name":"Tessier-Lavigne Marc","owner_url":"/insider/0001437435","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7830.0,"shares_display":"7,830","price_per_share":680.0,"price_display":"680.00","price_state":"stated","total_value":5324400.0,"total_display":"5,324,400.00","total_whole":"5,324,400","shares_owned_after":2269.0,"shares_owned_after_display":"2,269","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-17","filed_date":"2022-03-18","scope":"insider"},{"id":6500213,"accession":"0001708138-22-000020","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001708138-22-000020","line_url":"/filing/0001708138-22-000020#line-2","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS, INC.","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001437435","owner_name":"Tessier-Lavigne Marc","owner_display_name":"Tessier-Lavigne Marc","owner_url":"/insider/0001437435","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4361.0,"shares_display":"4,361","price_per_share":675.0,"price_display":"675.00","price_state":"stated","total_value":2943675.0,"total_display":"2,943,675.00","total_whole":"2,943,675","shares_owned_after":2269.0,"shares_owned_after_display":"2,269","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-16","filed_date":"2022-03-18","scope":"insider"},{"id":4952835,"accession":"0001714899-21-000117","txn_seq":16,"anchor":"line-16","filing_url":"/filing/0001714899-21-000117","line_url":"/filing/0001714899-21-000117","is_derivative":false,"issuer_cik":"0001437435","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001437435","owner_cik":"0001437435","owner_name":"Tessier-Lavigne Marc","owner_display_name":"Tessier-Lavigne Marc","owner_url":"/insider/0001437435","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20047.0,"shares_display":"20,047","price_per_share":45.361470045393325,"price_display":"45.36","price_state":"stated","total_value":909361.39,"total_display":"909,361.39","total_whole":"909,361","shares_owned_after":79648.0,"shares_owned_after_display":"79,648","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-12-30","filed_date":"2021-12-30","scope":"insider","n_lines":6},{"id":4952805,"accession":"0001714899-21-000117","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001714899-21-000117","line_url":"/filing/0001714899-21-000117","is_derivative":false,"issuer_cik":"0001437435","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001437435","owner_cik":"0001437435","owner_name":"Tessier-Lavigne Marc","owner_display_name":"Tessier-Lavigne Marc","owner_url":"/insider/0001437435","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":32104.0,"shares_display":"32,104","price_per_share":43.876667081983555,"price_display":"43.88","price_state":"stated","total_value":1408616.52,"total_display":"1,408,616.52","total_whole":"1,408,617","shares_owned_after":85650.0,"shares_owned_after_display":"85,650","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-12-29","filed_date":"2021-12-30","scope":"insider","n_lines":3},{"id":4952793,"accession":"0001714899-21-000117","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001714899-21-000117","line_url":"/filing/0001714899-21-000117","is_derivative":false,"issuer_cik":"0001437435","issuer_name":"Denali Therapeutics Inc.","issuer_ticker":"DNLI","issuer_name_source":null,"issuer_url":"/issuer/0001437435","owner_cik":"0001437435","owner_name":"Tessier-Lavigne Marc","owner_display_name":"Tessier-Lavigne Marc","owner_url":"/insider/0001437435","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10980.0,"shares_display":"10,980","price_per_share":44.37328051001821,"price_display":"44.37","price_state":"stated","total_value":487218.62,"total_display":"487,218.62","total_whole":"487,219","shares_owned_after":96268.0,"shares_owned_after_display":"96,268","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-12-28","filed_date":"2021-12-30","scope":"insider","n_lines":3},{"id":5411699,"accession":"0001237899-21-000027","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001237899-21-000027","line_url":"/filing/0001237899-21-000027#line-2","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS, INC.","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001437435","owner_name":"Tessier-Lavigne Marc","owner_display_name":"Tessier-Lavigne Marc","owner_url":"/insider/0001437435","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3784.0,"shares_display":"3,784","price_per_share":665.0,"price_display":"665.00","price_state":"stated","total_value":2516360.0,"total_display":"2,516,360.00","total_whole":"2,516,360","shares_owned_after":2078.0,"shares_owned_after_display":"2,078","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-09","filed_date":"2021-12-10","scope":"insider"},{"id":4399429,"accession":"0001708138-21-000080","txn_seq":20,"anchor":"line-20","filing_url":"/filing/0001708138-21-000080","line_url":"/filing/0001708138-21-000080#line-20","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS, INC.","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001437435","owner_name":"Tessier-Lavigne Marc","owner_display_name":"Tessier-Lavigne Marc","owner_url":"/insider/0001437435","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2098.0,"shares_display":"2,098","price_per_share":638.46,"price_display":"638.46","price_state":"stated","total_value":1339489.08,"total_display":"1,339,489.08","total_whole":"1,339,489","shares_owned_after":11098.0,"shares_owned_after_display":"11,098","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-13","filed_date":"2021-09-15","scope":"insider"},{"id":4399425,"accession":"0001708138-21-000080","txn_seq":19,"anchor":"line-19","filing_url":"/filing/0001708138-21-000080","line_url":"/filing/0001708138-21-000080#line-19","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS, INC.","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001437435","owner_name":"Tessier-Lavigne Marc","owner_display_name":"Tessier-Lavigne Marc","owner_url":"/insider/0001437435","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1645.0,"shares_display":"1,645","price_per_share":642.54,"price_display":"642.54","price_state":"stated","total_value":1056978.3,"total_display":"1,056,978.30","total_whole":"1,056,978","shares_owned_after":6260.0,"shares_owned_after_display":"6,260","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-13","filed_date":"2021-09-15","scope":"insider"},{"id":4399421,"accession":"0001708138-21-000080","txn_seq":18,"anchor":"line-18","filing_url":"/filing/0001708138-21-000080","line_url":"/filing/0001708138-21-000080#line-18","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS, INC.","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001437435","owner_name":"Tessier-Lavigne Marc","owner_display_name":"Tessier-Lavigne Marc","owner_url":"/insider/0001437435","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1549.0,"shares_display":"1,549","price_per_share":643.33,"price_display":"643.33","price_state":"stated","total_value":996518.17,"total_display":"996,518.17","total_whole":"996,518","shares_owned_after":4711.0,"shares_owned_after_display":"4,711","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-13","filed_date":"2021-09-15","scope":"insider"},{"id":4399417,"accession":"0001708138-21-000080","txn_seq":17,"anchor":"line-17","filing_url":"/filing/0001708138-21-000080","line_url":"/filing/0001708138-21-000080#line-17","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS, INC.","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001437435","owner_name":"Tessier-Lavigne Marc","owner_display_name":"Tessier-Lavigne Marc","owner_url":"/insider/0001437435","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1260.0,"shares_display":"1,260","price_per_share":639.45,"price_display":"639.45","price_state":"stated","total_value":805707.0,"total_display":"805,707.00","total_whole":"805,707","shares_owned_after":9838.0,"shares_owned_after_display":"9,838","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-13","filed_date":"2021-09-15","scope":"insider"},{"id":4399407,"accession":"0001708138-21-000080","txn_seq":16,"anchor":"line-16","filing_url":"/filing/0001708138-21-000080","line_url":"/filing/0001708138-21-000080#line-16","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS, INC.","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001437435","owner_name":"Tessier-Lavigne Marc","owner_display_name":"Tessier-Lavigne Marc","owner_url":"/insider/0001437435","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":981.0,"shares_display":"981","price_per_share":640.61,"price_display":"640.61","price_state":"stated","total_value":628438.41,"total_display":"628,438.41","total_whole":"628,438","shares_owned_after":8857.0,"shares_owned_after_display":"8,857","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-13","filed_date":"2021-09-15","scope":"insider"},{"id":4399405,"accession":"0001708138-21-000080","txn_seq":15,"anchor":"line-15","filing_url":"/filing/0001708138-21-000080","line_url":"/filing/0001708138-21-000080#line-15","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS, INC.","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001437435","owner_name":"Tessier-Lavigne Marc","owner_display_name":"Tessier-Lavigne Marc","owner_url":"/insider/0001437435","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":952.0,"shares_display":"952","price_per_share":641.56,"price_display":"641.56","price_state":"stated","total_value":610765.12,"total_display":"610,765.12","total_whole":"610,765","shares_owned_after":7905.0,"shares_owned_after_display":"7,905","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-13","filed_date":"2021-09-15","scope":"insider"},{"id":4399401,"accession":"0001708138-21-000080","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0001708138-21-000080","line_url":"/filing/0001708138-21-000080#line-14","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS, INC.","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001437435","owner_name":"Tessier-Lavigne Marc","owner_display_name":"Tessier-Lavigne Marc","owner_url":"/insider/0001437435","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":844.0,"shares_display":"844","price_per_share":644.52,"price_display":"644.52","price_state":"stated","total_value":543974.88,"total_display":"543,974.88","total_whole":"543,975","shares_owned_after":3867.0,"shares_owned_after_display":"3,867","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-13","filed_date":"2021-09-15","scope":"insider"}],"collapsed":true,"next_cursor":"2021-09-13|4399401","ledger_fault":false,"count":{"value":102,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":101,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":102},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001714899","name":"Denali Therapeutics Inc.","url":"/issuer/0001714899","role":"Director","n_filings":14,"first_seen":"2020-06-18","last_seen":"2022-11-28"},{"type":"issuer","type_label":"ISSUER","cik":"0000872589","name":"REGENERON PHARMACEUTICALS, INC.","url":"/issuer/0000872589","role":"Director","n_filings":11,"first_seen":"2013-05-08","last_seen":"2022-10-03"},{"type":"issuer","type_label":"ISSUER","cik":"0001439222","name":"AGIOS PHARMACEUTICALS INC","url":"/issuer/0001439222","role":"Director","n_filings":1,"first_seen":"2014-04-03","last_seen":"2014-04-03"},{"type":"issuer","type_label":"ISSUER","cik":"0000318771","name":"GENENTECH INC","url":"/issuer/0000318771","role":"Officer (EVP, RESEARCH DRUG DISCOVERY)","n_filings":1,"first_seen":"2008-07-18","last_seen":"2008-07-18"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001437435","retrieved_at":"2026-08-23T12:10:36+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}